Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.

Ajeganova S, Svensson B, Hafström I; BARFOT Study Group.

BMJ Open. 2014 Apr 7;4(4):e004259. doi: 10.1136/bmjopen-2013-004259.

PMID:
24710131
[PubMed]
Free PMC Article
2.

Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study.

Svensson B, Hafström I, Erlandsson MC, Forslind K, Bokarewa MI.

Arthritis Res Ther. 2014 Jan 16;16(1):R12. [Epub ahead of print]

PMID:
24428870
[PubMed - as supplied by publisher]
Free PMC Article
3.

Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.

Su J, Frostegård AG, Hua X, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

J Rheumatol. 2013 Nov;40(11):1856-64. doi: 10.3899/jrheum.121173. Epub 2013 Sep 15.

PMID:
24037548
[PubMed - indexed for MEDLINE]
4.

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria.

Svensson B, Andersson ML, Bala SV, Forslind K, Hafström I; BARFOT study group.

BMJ Open. 2013 Sep 10;3(9):e003554. doi: 10.1136/bmjopen-2013-003554.

PMID:
24022393
[PubMed]
Free PMC Article
5.

Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.

Ajeganova S, Andersson ML, Frostegård J, Hafström I.

J Rheumatol. 2013 Dec;40(12):1958-66. doi: 10.3899/jrheum.130365. Epub 2013 Aug 15.

PMID:
23950188
[PubMed - in process]
6.

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Andersson ML, Svensson B, Petersson IF, Hafström I, Albertsson K, Forslind K, Heinegård D, Saxne T.

BMC Musculoskelet Disord. 2013 Aug 2;14:229. doi: 10.1186/1471-2474-14-229.

PMID:
23915292
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Dr. Ajeganova and Dr. Hafström reply.

Ajeganova S, Hafström I.

J Rheumatol. 2013 Mar;40(3):337. No abstract available.

PMID:
23577349
[PubMed - indexed for MEDLINE]
8.

Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction.

Engvall IL, Svensson B, Boonen A, van der Heijde D, Lerner UH, Hafström I; BARFOT study group.

Rheumatology (Oxford). 2013 Apr;52(4):733-42. doi: 10.1093/rheumatology/kes369. Epub 2012 Dec 28.

PMID:
23275387
[PubMed - indexed for MEDLINE]
9.

Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?

Forslind K, Kälvesten J, Hafström I, Svensson B; for the BARFOT Study Group.

Arthritis Res Ther. 2012 Oct 15;14(5):R219. [Epub ahead of print]

PMID:
23068060
[PubMed - as supplied by publisher]
Free PMC Article
10.

Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis.

Elkan AC, Anania C, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

Lupus. 2012 Nov;21(13):1405-11. doi: 10.1177/0961203312458471. Epub 2012 Aug 28.

PMID:
22930204
[PubMed - indexed for MEDLINE]
11.

Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.

Ajeganova S, de Faire U, Jogestrand T, Frostegård J, Hafström I.

J Rheumatol. 2012 Jun;39(6):1146-54. doi: 10.3899/jrheum.111334. Epub 2012 May 15.

PMID:
22589258
[PubMed - indexed for MEDLINE]
12.

Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset.

Ajeganova S, Andersson ML, Hafström I; BARFOT Study Group.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):78-87. doi: 10.1002/acr.21710.

PMID:
22514159
[PubMed - indexed for MEDLINE]
13.

[Rheumatologic research with animal experiments is important for our patients].

Rudin A, Sturfelt G, Carlsten H, Hafström I, Lundberg I, Klareskog L, Rönnblom L, Jacobsson L, van Vollenhoven R, Rantapää-Dahlqvist S, Skogh T, Saxne T.

Lakartidningen. 2012 Jan 11-17;109(1-2):40. Swedish. No abstract available.

PMID:
22468412
[PubMed - indexed for MEDLINE]
14.

Microcirculation as determined by iontophoresis in SLE-patients and controls.

Anania C, Norman M, Heimburger M, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

Lupus. 2012 Jul;21(8):815-20. doi: 10.1177/0961203312439117. Epub 2012 Mar 13.

PMID:
22415927
[PubMed - indexed for MEDLINE]
15.

Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study.

Ajeganova S, Fiskesund R, de Faire U, Hafström I, Frostegård J.

Clin Exp Rheumatol. 2011 Nov-Dec;29(6):942-50. Epub 2011 Dec 22.

PMID:
22153361
[PubMed - indexed for MEDLINE]
16.

Effects on joint destruction and remission, bone turnover and lack of influence on atherogenesis: a review of the BARFOT low-dose prednisolone studies on patients with early RA.

Svensson B, Hafström I.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S63-7. Epub 2011 Oct 21. Review.

PMID:
22018186
[PubMed - indexed for MEDLINE]
17.

Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study.

Ajeganova S, Ehrnfelt C, Alizadeh R, Rohani M, Jogestrand T, Hafström I, Frostegård J.

Rheumatology (Oxford). 2011 Oct;50(10):1785-93. doi: 10.1093/rheumatology/ker204. Epub 2011 Jul 9.

PMID:
21743088
[PubMed - indexed for MEDLINE]
Free Article
18.

Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.

Tesfa D, Ajeganova S, Hägglund H, Sander B, Fadeel B, Hafström I, Palmblad J.

Arthritis Rheum. 2011 Aug;63(8):2209-14. doi: 10.1002/art.30427.

PMID:
21560117
[PubMed - indexed for MEDLINE]
Free Article
19.

Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass--a cross sectional study.

Elkan AC, Håkansson N, Frostegård J, Hafström I.

BMC Musculoskelet Disord. 2011 Jan 14;12:13. doi: 10.1186/1471-2474-12-13.

PMID:
21235741
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study.

Engvall IL, Brismar K, Hafström I, Tengstrand B.

Scand J Rheumatol. 2011 May;40(3):161-8. doi: 10.3109/03009742.2010.523012. Epub 2010 Nov 16.

PMID:
21077801
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk